Emergent BioSolutions (EBS) Finished Goods (2011 - 2018)

Emergent BioSolutions' Finished Goods history runs 8 years deep, the most recent figure standing at $50.8 million for Q4 2018.

• On a quarterly basis, Finished Goods rose 68.77% year-over-year to $50.8 million in Q4 2018; TTM through Dec 2018 was $50.8 million, a 68.77% increase from a year earlier, with the FY2018 full-year figure at $50.8 million, up 68.77% from the prior year.
• Finished Goods grew to $50.8 million in Q4 2018 per EBS's latest filing, from $27.1 million in the prior quarter.
• Across five years, Finished Goods topped out at $50.8 million in Q4 2018 and bottomed at $6.9 million in Q4 2015.
• The 5-year median for Finished Goods is $23.9 million (2015), against an average of $23.0 million.
• Across the five-year window, Finished Goods soared 669.76% in 2014 and plunged 58.88% in 2017, its largest moves.
• Year by year, Finished Goods stood at $14.8 million in 2014, then slumped by 53.43% to $6.9 million in 2015, then jumped by 240.34% to $23.5 million in 2016, then rose by 28.12% to $30.1 million in 2017, then soared by 68.77% to $50.8 million in 2018.
• Per Business Quant, the three latest EBS Finished Goods figures stand at $50.8 million (Q4 2018), $27.1 million (Q3 2018), and $25.4 million (Q2 2018).